YOR342C Antibody

What is YOR342C and why is it important in research?

YOR342C refers to a specific gene in Saccharomyces cerevisiae (Baker's yeast) that encodes a protein of interest in yeast biology. Antibodies against this protein are crucial research tools for studying yeast cellular processes, protein interactions, and gene expression patterns. The YOR342C antibody specifically recognizes and binds to its target protein in S. cerevisiae strain ATCC 204508 / S288c, enabling researchers to detect, quantify, and characterize this protein in experimental settings . Understanding YOR342C function contributes to our broader knowledge of yeast biology, which serves as an important model organism for eukaryotic cellular processes.

What are the key specifications of commercially available YOR342C antibodies?

YOR342C antibodies are typically polyclonal antibodies raised in rabbits using recombinant Saccharomyces cerevisiae YOR342C protein as the immunogen. They are available in liquid form, stored in buffer containing preservatives such as 0.03% Proclin 300 and constituents like 50% Glycerol and 0.01M PBS at pH 7.4. These antibodies are commonly purified using antigen affinity methods and are specific for S. cerevisiae strains like ATCC 204508 / S288c . They are intended strictly for research purposes and should not be used in diagnostic or therapeutic applications. Lead times for custom orders can range from 14-16 weeks, which should be factored into research planning timelines .

How should YOR342C antibodies be properly stored and handled?

For optimal results, YOR342C antibodies should be stored at -20°C or -80°C upon receipt. Repeated freeze-thaw cycles should be avoided as they can compromise antibody integrity and performance. Many commercial preparations contain 50% glycerol in their storage buffer, which helps maintain stability during freezing and thawing processes . For short-term use, antibodies can be kept at 4°C for up to one week, but should be returned to appropriate freezer storage for longer periods. Always centrifuge the product briefly before opening the tube to ensure all material is at the bottom of the vial, and use clean pipette tips when removing aliquots to prevent contamination.

What experimental considerations are important when designing studies with YOR342C antibody?

When designing experiments with YOR342C antibody, researchers should first determine appropriate antibody concentrations through titration experiments. This involves testing a range of dilutions (typically 1:500 to 1:5000) to identify optimal signal-to-noise ratios. Controls are critical and should include: 1) negative controls using non-immune serum or IgG, 2) positive controls using known YOR342C-expressing samples, and 3) blocking peptide controls to confirm specificity. When conducting comparative analyses, standardization of protein loading (for Western blots) or cell numbers (for immunocytochemistry) is essential. Additionally, researchers should validate the antibody's performance in their specific experimental conditions before conducting full-scale experiments, as outlined in antibody validation protocols used for other research antibodies .

What is the detection limit for YOR342C antibody and how can it be optimized?

While the specific detection limit for YOR342C antibody isn't directly provided in the available literature, we can draw insights from studies on detection limits of similar research antibodies. Based on antibody detection studies, most research-grade antibodies can detect their target proteins when they constitute approximately 1-5% of the total protein in a sample . To optimize detection sensitivity:

• Use enhanced chemiluminescence (ECL) substrates with higher sensitivity for Western blotting

• Implement signal amplification methods like tyramide signal amplification for immunohistochemistry

• Increase antibody incubation times (overnight at 4°C often improves sensitivity)

• Utilize replicate analysis, as studies show that multiple replicates can enable identification of proteins at concentrations as low as 0.1%

A systematic approach to optimization might include a factorial design examining variables such as antibody concentration, incubation time, buffer composition, and detection methods, similar to approaches used for other antibody systems .

What validated applications exist for YOR342C antibody?

YOR342C antibody has been validated for several applications including:

• Enzyme-Linked Immunosorbent Assay (ELISA): For quantitative detection of YOR342C protein in solution

• Western Blotting (WB): For detecting denatured YOR342C protein in cell or tissue lysates

When applying these methods, researchers should ensure proper identification of the antigen by verifying the molecular weight of detected bands (for WB) or using appropriate standards (for ELISA). While these are the established applications, researchers exploring other potential applications like immunohistochemistry, immunofluorescence, or chromatin immunoprecipitation should conduct thorough validation studies to confirm antibody performance in these contexts .

How can YOR342C antibody be utilized in protein interaction studies?

For investigating protein interactions involving YOR342C, researchers can employ several advanced techniques:

• Co-immunoprecipitation (Co-IP): Use YOR342C antibody to pull down the target protein along with its interaction partners from yeast cell lysates. Follow with mass spectrometry analysis to identify binding partners.

• Proximity Ligation Assay (PLA): Combine YOR342C antibody with antibodies against suspected interaction partners to visualize and quantify protein-protein interactions in situ with subcellular resolution.

• Bimolecular Fluorescence Complementation (BiFC): Tag YOR342C and potential interacting proteins with complementary fragments of fluorescent proteins to directly visualize interactions.

When interpreting results, consider that interactions may be transient or condition-dependent, similar to how phosphorylation events in yeast signaling pathways can affect protein interactions, as seen with Glc7/Protein Phosphatase 1 regulatory subunits . Validate interactions using reciprocal approaches and multiple experimental conditions to ensure biological relevance.

What considerations are important when using YOR342C antibody in phosphorylation studies?

When studying phosphorylation status of YOR342C or related proteins:

Drawing parallels from yeast phosphorylation research, studies involving Glc7/Protein Phosphatase 1 have shown that dephosphorylation of specific targets (rather than direct regulation of kinases like Ipl1) can be critical for accurate chromosome segregation . Similar mechanisms might apply to YOR342C, requiring careful experimental design to distinguish direct phosphorylation events from downstream effects.

How can mass spectrometry complement YOR342C antibody-based approaches?

Mass spectrometry (MS) offers powerful complementary approaches to antibody-based detection of YOR342C:

• Protein Identification and Validation: MS can confirm the identity of bands detected by YOR342C antibody in Western blots.

• Post-translational Modifications: MS can map specific modification sites on YOR342C protein that might not be detectable with general antibodies.

• Quantitative Analysis: When combined with techniques like SILAC (Stable Isotope Labeling with Amino acids in Cell culture), MS enables precise quantification of YOR342C protein levels across different conditions.

MS analysis typically involves:

When implementing this approach, researchers should be aware that protein sequence composition can result in peptides that aren't amenable to analysis by bottom-up MS (too short, too small, or not ionizable), and sequence homology can complicate data interpretation .

What are common challenges in Western blotting with YOR342C antibody and how can they be addressed?

Researchers commonly encounter several challenges when performing Western blots with YOR342C antibody:

• High Background:

  • Cause: Insufficient blocking, too high antibody concentration, or contaminated buffers

  • Solution: Optimize blocking conditions (test 5% milk vs. BSA), titrate antibody concentration, and prepare fresh buffers

• Weak or No Signal:

  • Cause: Insufficient protein loading, protein degradation, inefficient transfer, or suboptimal antibody dilution

  • Solution: Increase protein amount, add protease inhibitors during sample preparation, optimize transfer conditions, and adjust antibody concentration

• Multiple Bands:

  • Cause: Cross-reactivity, protein degradation, or post-translational modifications

  • Solution: Validate with knockout/knockdown controls, add protease inhibitors, and compare with literature data on known modifications

• Inconsistent Results:

  • Cause: Variations in sample preparation or experimental conditions

  • Solution: Standardize protocols, use internal loading controls, and implement replicate analysis, which has been shown to enhance detection consistency even for low-abundance proteins

A systematic troubleshooting approach similar to that used in antibody validation studies for other research applications can significantly improve results .

How should researchers address contradictory results between YOR342C antibody-based detection and other methods?

When faced with discrepancies between YOR342C antibody results and other detection methods:

• Verify Antibody Specificity:

  • Perform validation experiments using knockout/knockdown approaches

  • Test with blocking peptides to confirm binding specificity

  • Consider epitope availability in different experimental contexts

• Evaluate Method Limitations:

  • Consider that different methods may detect different epitopes or conformations

  • Assess whether post-translational modifications might affect antibody recognition

  • Review sample preparation differences that might explain discrepancies

• Integrate Multiple Approaches:

  • Use orthogonal methods such as MS-based proteomics to resolve contradictions

  • Consider quantitative PCR to correlate protein with mRNA levels

  • Design experiments that can distinguish between technical and biological sources of variation

• Statistical Analysis:

  • Apply appropriate statistical methods to determine significance of discrepancies

  • Consider integrating results using Bayesian approaches that can weigh evidence from multiple sources

When interpreting contradictory results, remember that different detection thresholds exist for different methods. For instance, MS-based proteomics can sometimes detect proteins at concentrations as low as 0.1% of the sample, while standard antibody-based methods may require targets to constitute at least 1-5% of the sample for reliable detection .

What controls are essential for validating results with YOR342C antibody?

Comprehensive validation of YOR342C antibody results requires multiple controls:

• Positive Controls:

  • Samples known to express YOR342C protein (e.g., specific yeast strains)

  • Recombinant YOR342C protein at known concentrations for quantitative applications

• Negative Controls:

  • YOR342C knockout/knockdown samples when available

  • Related yeast species or strains known not to express YOR342C

  • Non-immune IgG from the same species as the primary antibody

• Specificity Controls:

  • Pre-adsorption/blocking peptide experiments where antibody is pre-incubated with excess antigen

  • Sequential probing with different antibodies targeting the same protein

• Technical Controls:

  • Loading controls (e.g., housekeeping proteins) for Western blotting

  • Isotype controls for flow cytometry applications

  • Multiple dilutions of antibody to demonstrate dose-dependent effects

• Replicate Analysis:

  • Technical replicates to assess method reproducibility

  • Biological replicates to account for natural variation

This multi-layered control strategy is similar to validation approaches used for therapeutic antibodies like BYON4228, where extensive preclinical characterization included multiple specificity controls to confirm target binding .

How does YOR342C antibody compare to other antibodies targeting yeast proteins?

When comparing YOR342C antibody to other yeast protein antibodies:

Specificity Considerations:

• YOR342C antibody is strain-specific, primarily recognizing the protein in S. cerevisiae strain ATCC 204508 / S288c

• Other yeast antibodies may have broader cross-reactivity across multiple strains or even species

Application Range:

• YOR342C antibody has been validated for ELISA and Western blotting applications

• Other yeast antibodies may offer broader application profiles including immunofluorescence, ChIP, or flow cytometry

Production and Quality:

• As a polyclonal antibody, YOR342C antibody preparations may show lot-to-lot variability

• Monoclonal antibodies against other yeast proteins offer greater consistency but potentially narrower epitope recognition

When selecting between different antibodies, researchers should consider:

• The specific strain and experimental conditions

• The required applications and detection methods

• Whether polyclonal breadth or monoclonal specificity is more important for their research questions

What databases and resources can help researchers working with YOR342C antibody?

Researchers working with YOR342C antibody can benefit from several specialized databases and resources:

• Antibody Databases:

  • The Patent and Literature Antibody Database (PLAbDab) provides literature-annotated antibody sequences and structures that can inform experimental design

  • Antibody Registry (antibodyregistry.org) assigns unique identifiers to antibodies to enhance reproducibility

• Yeast-Specific Resources:

  • Saccharomyces Genome Database (SGD) provides comprehensive information about YOR342C gene and protein

  • Yeast GFP Fusion Localization Database offers insights into YOR342C protein localization

• Experimental Protocol Repositories:

  • Protocols.io hosts community-contributed experimental protocols for antibody-based applications

  • STAR Methods (Structured, Transparent, Accessible Reporting) in published literature provide detailed methodological information

• Data Analysis Tools:

  • IEDB Analysis Resource offers tools for epitope analysis and antibody specificity prediction

  • MS-based proteomics platforms like MaxQuant support integrated analysis of antibody-based and MS-based data

These resources can help researchers design better experiments, interpret results more effectively, and place their findings in broader context. For example, comparing search methods across antibody databases has been shown to yield different numbers of retrieved entries and functional consistency, making comprehensive database searches crucial for thorough research .

How can researchers integrate YOR342C antibody studies with broader -omics approaches?

Integration of YOR342C antibody studies with broader -omics approaches enables more comprehensive insights:

• Proteomics Integration:

  • Combine targeted YOR342C detection with global proteome analysis

  • Use techniques like SILAC or TMT labeling for quantitative comparisons

  • Apply multi-enzyme digestion approaches (similar to those used for serum antibody analysis) to improve protein coverage

• Transcriptomics Correlation:

  • Compare YOR342C protein levels (detected by antibody) with mRNA expression

  • Investigate potential post-transcriptional regulation mechanisms

  • Develop integrated models of gene expression and protein abundance

• Metabolomics Connections:

  • Link YOR342C protein function to metabolic pathways

  • Investigate conditional relationships between protein abundance and metabolite levels

  • Apply network biology approaches to place YOR342C in broader cellular context

• Systems Biology Framework:

  • Design experimental matrices that systematically vary conditions while measuring multiple -omics endpoints

  • Apply computational models to integrate diverse data types

  • Develop testable hypotheses about YOR342C function in cellular networks

This integrated approach resembles strategies used in cutting-edge antibody research like that seen with BYON4228, where multiple complementary analytical methods were combined to develop a comprehensive functional profile .

What emerging technologies might enhance YOR342C antibody applications?

Several emerging technologies have the potential to significantly enhance YOR342C antibody applications:

• Single-Cell Proteomics:

  • Mass cytometry (CyTOF) combined with YOR342C antibody could enable high-dimensional single-cell protein profiling

  • Microfluidic antibody capture techniques may allow assessment of YOR342C expression in individual yeast cells

• Spatial Biology Approaches:

  • Multiplexed ion beam imaging (MIBI) or imaging mass cytometry could map YOR342C distribution in relation to other proteins

  • Spatial transcriptomics combined with antibody detection could correlate protein localization with local gene expression

• Advanced Microscopy:

  • Super-resolution microscopy with YOR342C antibody could reveal previously undetectable subcellular localization patterns

  • Live-cell imaging with antibody fragments might enable dynamic studies of YOR342C behavior

• Protein Engineering:

  • Nanobody or single-domain antibody development against YOR342C could offer superior tissue penetration and recognition of cryptic epitopes

  • CRISPR-based tagging strategies combined with antibody detection could enable endogenous tracking of YOR342C

These technologies, while still emerging for application to yeast proteins like YOR342C, have shown promise in other research areas, such as the development of VHH antibodies (nanobodies) that have advantages over conventional antibodies for certain applications .

What are the most pressing methodological challenges in YOR342C research?

Researchers face several critical methodological challenges when working with YOR342C:

• Antibody Validation Standards:

  • Developing consensus standards for validating YOR342C antibody specificity and sensitivity

  • Establishing reproducible protocols across different laboratories and experimental systems

• Quantification Challenges:

  • Improving absolute quantification of YOR342C protein in complex samples

  • Developing better internal standards for quantitative applications

• Structural Recognition:

  • Understanding how different sample preparation methods affect epitope availability

  • Developing antibodies that can distinguish between different conformational states

• Dynamic Analysis:

  • Creating methods to study real-time changes in YOR342C levels or modifications

  • Developing approaches to correlate antibody-based detection with functional outcomes

• Cross-Platform Integration:

  • Harmonizing data from antibody-based detection with other analytical platforms

  • Establishing computational frameworks to integrate diverse experimental results

These challenges mirror those faced in broader antibody research fields, where methodological standardization and validation remain critical priorities for ensuring reproducible and meaningful experimental results .